Pleo Nota-Quent (Sanum-Kehlbeck GmbH & Co. KG)


Welcome to the PulseAid listing for the Pleo Nota-Quent drug offered from Sanum-Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanum-Kehlbeck GmbH & Co. KG
NON-PROPRIETARY NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM and PENICILLIUM GLABRUM
SUBSTANCE NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-04-15
END MARKETING DATE: 0000-00-00


Pleo Nota-Quent HUMAN OTC DRUG Details:

Item DescriptionPleo Nota-Quent from Sanum-Kehlbeck GmbH & Co. KG
LABELER NAME: Sanum-Kehlbeck GmbH & Co. KG
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 5([hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2012-04-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60681-0031_65b23a17-dfdc-4fe5-86f6-08933ebd6bfa
PRODUCT NDC: 60681-0031
APPLICATION NUMBER:

Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BioResource Inc.Notatum-Quentans Nasal 4X
sanPharma GmbHNotaQuenSAN
Sanum-Kehlbeck GmbH & Co. KGPleo Nota-Quent
Syntrion GmbHSyInfect
USPharmaCoNotatum-Quentans